Peptic ulcer in polyendocrine disease: cause and effect by Howe, Caroline
Boston University
OpenBU http://open.bu.edu
Theses & Dissertations Dissertations and Theses (pre-1964)
1963
Peptic ulcer in polyendocrine
disease: cause and effect
Howe, Caroline
Boston University
https://hdl.handle.net/2144/25786
Boston University
PEPTIC ULCER IN POLYENDOCRINE DISEASE 
Cause and Effect? 
Caroline Howe 
BtJ.:iM III 
March, .1.963 
TABLE OF CONTENTS 
INTRODUCTION 
Definition of polyendocrine disease 
Historical 
CELL TYPE AND THE SINGLE ADENOMA 
Pituitary 
Parathyroids 
Pancreas 
POSSIBLE CLINICAL COMBINATIONS IN POLYENDOCRINE DISEASE 
THE TUMORS OF POLYENDOCRINE DISEASE 
Pituitary tumors 
Parathyroid tumors 
Pancreatic tumors 
Beta cell tumors 
Non-bet a cell tumors 
Pathological features 
Radiological features 
Clinical features 
Histology 
Experimental 
OTHER ORGAN SYSTEMS 
Adrenal cortex 
Thyroid 
Gonads 
ETIOLOGY 
11 End organ failure" 
Phosphorus metabolism 
Genetic 
SUMMARY 
COMMENT 
Page 
l 
l 
2 
3 
3 
4 
4 
5 
6 
6 
6 
9 
10 
ll 
ll 
12 
14 
16 
17 
23 
23 
24 
24 
25 
25 
26 
26 
28 
29 
INTRODUCTION 
The literature is filled with reports of adenomas coexisting in two 
endocrine glands. These may or may not be coincidental findings . However, 
adenomatous involvement of three or more endocrine glands is a much rarer 
finding, and despite some unusual manifestations, has only recently anoused 
much interest . Investigation of the literature indicates that multiple 
endocrine adenomas are not merely coincidental occurrences, as it might 
seem at first glance, but rather constitute a distinct disease with a single 
etiology Which, because of the var iety of organs involved produces a vast 
array of clinical signs and s,ymptoms in a multitude of combinations. For 
the purposes of this discussion, only those cases which indicate an involve-
ment of the following three organs , the anterior pituitary, the parathyroids, 
and the islands of Langerhans of the pancreas, will be treated as repre-
senting cases of multiple endocrine adenomata or polyendocrine disease. 
The presence of peptic ulcer is a very important and frequent finding 
in patients with polyendocrine disease . These ulcers are characteristic-
ally large, severe, and intractable, such that when a case of peptic ulcer 
of this sort is detected clinically, an investigat ion for the presence of 
polyendocrine disease is warranted . The pathogenesis of peptic ulcer in 
polyendocrine disease raises some interesting questions, which to date 
remain unresolved . However, two major trends of thought have arisen out 
of the observations and descriptions of known cases of polyendocrine disease, 
neither of which can yet be accepted or rejected on the basis of scientific 
proof . One opinion claims that peptic ulcer should be regarded as a sec-
ondary effect of disordered endocrine function, while the other opinion 
h0lds that peptic ulcer in polyendocrine disease is the result of a single 
genetic defect which causes disease in the endocrine organs and peptic 
ulceration as well. 
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The first case of polyendocrine disease was described by Llqyd in 
1929. (25) A 22-~ear old Spanish girl with a large inoperable hypophyseal 
tumor was found at autopsy to have a chromophobe adenoma of the pituitary, 
multiple tumor-like nodules in the parathyroids, and also in the islands 
of Langerhans. In addition the ovaries contained numerous cysts. Interest-
ingly, this patient presented no evidence of disease clinically except in 
the pituitary. Consequently, no blood chemistries or clinical data was 
obtained. 
It was not until the early 1940's that a patient was recognized to 
have multiple endocrine disease as well as peptic ulcer, clinically, and 
to receive treatment for it. (47) The patient, a 26-year old sailor, was 
discovered to have hyperinsulinism while he was recovering from an oper-
ation for a ureteral stone. Pancreatic surgery a little later revealed 
three adenomas of the islands of Langerhans. Recurrence of the kidney 
stones, elevated serum calcium and hypercalciuria prompted exploration of 
the parathyroids. An adenoma was found at operation. A pituitary tumor 
was diagnosed because of visual field defects in both temporal quadrants 
and radiographic evidence revealed an enlarged sella turcica. Moreover, 
this patient had a large duodenal ulcer which caused massive hemorrhages 
over a period of two years. In addition, he had loss of libido, and 
alopecia. 
One intriguing aspect of adenomatous involvement of the pituitary, 
parathyroids, and pancreas is the identification of a single factor which 
would produce disease in three seemingly unrelated endocrine organs. To 
date, the existence of trophic hormones has not been established between 
the pituitary and parathyroids, or the pituitary and pancreas. (29, 55) 
Indeed, the parathyroids are unaffected by destruction of the anterior 
pituitary. Tumors of one gland can't induce tumors of the other two. 
~-----------·~-------------------
(55) 
-
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The question of etiology will be discussed after a consideration of the 
manifestations of polyendocrine disease . 
CELL TYPE AND THE SINGLE ADENOMA 
The clinical manifestations of a single adenoma of each gland with 
respect to cell type will serve to orient the reader toward the variety 
of combinations that is possible in this disease. 
The pituitary is composed of an undetermined number of cell types. 
Routine preparations show eosinophiles, basophiles, and chromophobes . Eos-
inophiles and basophiles are functional, and after their secretions have 
been liberated they return to the chromophobe type. (56) Close examination 
of some chromophobes reveals the presence of faint acidophilic and baso-
philic granules. Consequently these cells are referred to as amphophiles. 
Russfield classifies pituitary cells by their staining reaction with per-
iodic acid-Schiff and counterstained with orange-G. Five cell types are 
defined by this technique: 1) basophiles, containing darR red granules; 
2) acidophiles, Schiff negative bub bright orange with counterstain; 3) 
chromophobes, agranular; 4) amphophiles, pleomorphic, with some dark red 
or orange granules which are faintly positive, and with extreme variability 
in size, number and distribution; and 5) hypertrophic amphophiles, pleomor-
phic, but with a degranulated, diminished cytoplasm and a strikingly enlarged 
nucleus . Theoretically, each of these cell types can undergo adenomatous 
development or hyperplasia . 
It is generally accepted that eosinophilic tumors produce acromegaly . 
(8, 56) Basophilic adenomas are associated with bilateral hyperplasia with 
widening of the adrenal cortex, sometimes resulting in Cushing! s disease, 
but more often not . These adenomas are usually small and do not cause 
enlargement of the sella turcica. They are estimated to be present in as 
many as 15% of all autopsies . (56) 
-
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The chromophobe adenoma presents a confusing picture which st ill 
remains to be settled. Chromophobe adenomas are usually considered to be 
non-functional tumors, and their clinical manifestations are related to 
destruction of the sella turcica and the resultant pan-hypopituitarism. 
When gradual pituitary destruction occurs, corticotropin is one of the last 
hormones to become deficient. However, there is some evidence which impli-
cates chromophobe adenomas in Cushing's disease. Examination of cortico-
tropin-secreting tumors has revealed an absence of the large secretory 
granules anticipated. Rather, chromophobe tumors which contain fine, 
sparse granulation have been found with the periodic acid- Schiff stain. 
At the Mayo Clinic 12 cases of such chromophobe adenomas were found in a 
series of 122 cases of Cushing ' s disease . (56) These tumors were considered 
to be of the amphophil cell type . 
The parathyroids are composed of two main cell types, chief cells and 
oxyphiles. The chief cells are further subdivided into Wasserhelle and 
dark types. (8) Byperfunction of either chief cells or Wasserhelle cells 
is presumed to cause one clinical disease which is manifested by kidney 
stones, bone cysts, and/or osteoporosis, hypercalcemia and phosphaturia. 
The symptoms are vague and clinical recognition often occurs after such 
complications as renal calculi or bone fractures have occurred . (5) However, 
not all parathyroid adenomas are functioning . The true incidence of non-
functioning adenomas is not known due to the lack of autopsy information. 
Adenomas composed of oxyphiles are not implicated as a cause of disease . 
Adenomas of the parathyroids are composed of all cell types, singly or in 
mixtures. Wasserhelle cells are generally associated with hyperplasia. 
The islands of Langerhans are thought to be composed of three cell 
types, alpha, beta, and delta cells. (8) Adenomas composed of beta cells 
are called insulinomas, and they cause low blood sugar levels due to the 
l 
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hypersecretion of insulin. Alpha cells are associated with glucagon secre-
tion, and adenomas are thought to be non-functioning. (56) Delta cells, 
still difficult to differentiate from alpha cells by the presently avail-
able staining techniques, are implicated in the Zollinger-Ellison syndrome. 
This syndrome is characterized by: 1) fulminating ulcer diathesis; 2) 
marked gastric hypersecretion; and 3) a non-insulin producing islet cell 
tumor of the pancreas. (36) This syndrome will be dealt with in more 
detail later . 
Since an adenoma or hyperplasia is present in each gland according 
to the definition used here for polyendocrine disease, then it is conceiv-
abl~at many combinations of disorders could result. From inspection of 
the cases repnrted, this seems to occur and is most likely the reason that 
polyendocrine disease is so ill- defined and that the literature is so con-
fusing on this subject. 
One common disorder is apparent on inspection of the lists of possible 
manifestations of multiple endocrinopathies . Peptic ulcers have been asso-
ciated with disease of the pituitary, of the parathyroids, and of the pan-
creas. This observation alone is suggestive of an endocrinologic patho-
genesis for the ulcers associated with multiple endocrine adenomas, since 
peptic ulcer is frequently found to be associated with disease of each of 
these three organs individually. 
POSSIBLE CLINICAL COMBINATIONS IN POLYENDOCRINE DISEASE 
PITUITARY 
visual field defects 
acromegaly 
headaches 
Cushing's disease 
ganadal atrophy 
amenorrhea 
hyperthyroidism 
pan-hypopituitarism 
peptic ulcer 
PARATHYROIDS 
renal calculi 
osteoporosis 
nephrocalcinosis 
decreased muscular tone 
vonRecklinghausen's 
disease of bone 
pancreatitis 
peptic ~ 
PANCREAS 
hypoglycemia 
hyperglycemia? 
steatorrhea 
diarrhea 
peptic ~ 
-
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THE TUMORS OF POLYENDOCRINE DISEASE 
As mentioned previously, the pituitary may form at least three types 
of adenomas or, rarely, mixed types . CLinically, pituitary tumors should 
be suspected when there are defects in the visual fields, or when there 
is radioaogic evidence of enlargement of the sella turcica . The visual 
field defects are almost always located in the temporal quadrants from 
impingement on the optic chiasm. Basophilic adenomas will not usually be 
diagnosed clinically since they generally do not cause enlargement of the 
sella turcica or clinical s.rmptomatology. (56) 
In an autopsy study of ulcers, Ellison, Abrams , and Smith found 812 
cases of ulcer in 20,000 autopsies, and of these 812, nine had pituitary 
pathology. (14) These were : 1 eosinophilic adenoma, 1 basophilic adenoma, 
1 chromophobe adenoma, and six cases of cellular hyperplasia comprised of 
four basophilia and two eosinophilia. MOreover, none of these had lesions 
in more than one endocrine gland. 
Roth and Vilardell feel that it is unlikely that any physiological 
relationship exists between specific pituitary adenomas and peptic ulcer 
disease because all cell t~es are involved in multiple adenomas. (39) 
Eosinophilic tumors have been reported to be associated with an ulcero-
genic tendency . However, the true incidence in polyendocrine disease has 
yet to be established. (59) Much data with regard to the presence or absence 
of pituitary tumors has been lost due to lack of autopsy information, and 
it is conceivable that some cases in which parathyroid and pancreatic tumors 
are found, that pituitary tumors are present but clinically undetectable. 
Hyperparathyroidism is frequently an insidious disorder, and when it 
is present in polyendocrine disease, it appears to be even more so. Cope 
regards hyperparath7roidism as an asymptomatic disorder which is detected 
when one of its complications emerges . (5, 6) Underdahl, et al, think it 
·-
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is often sub-clinically present in polyendocrine disease, and found by 
accident in association with an enlarged pituitary, or hyperinsulinism, 
or other suspicious disorder. (50) Some cases of polyendocrine disease 
have been discovered because the initial symptomatology was related to 
renal lithiasis and/or peptic ulcer . (47) 
Peptic ulcer, when it is associated with hyperparathyroidism only, 
occurs in the usual sites of peptic ulceration. Once the hyperparathyroid-
ism is corrected by surgery, ulcers have been observed to subside promptly. 
(6) The true incidence of associated peptic ulcer has not been established, 
but it is thought to be clinically significant. Cope's series of 230 cases 
reported 19 patients with associated peptic ulcer. Zollinger and Craig 
found a 13% incidence . (60) 
Little is known about the mechanism involved in the production of 
peptic ulcer in hyperparathyroidism. When peptic ulcer is present, it tands 
to be in males and to be duodenal in location. (19) Experiments using 
parathormone injected into dogs show an increase in the volume of gastric 
juice. (48) Pre- and post-operative studies on patients with hyperparathy-
roidism show that there is an increase in both total pepsin and secretory 
volume when parathormone levels are elevated. (11) Schiffrin's experiments 
showed diminished volume and acidity but an increased pepsin concentration 
on Pavlov pouch dogs. (44) In Heidenhain pouch dogs an increased volume 
and acidity were found with the pepsin factor unaffected . 
Calcium in the gastric secretions is thought to be an important factor 
in the production of ulcers. Human gastric juice contains 2.0-4.3 mEq Ca/L 
in the fasting state. (51) Mucous secreted from the surface epithelial 
cells of the stomach supplies an immediate source of calcium. (20) Since 
mucous reduces gastric acidity, a reciprocal relationship between the 
calcium concentration and gastric acidity can be seen to exist. In hyper-
I 
--
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thyroidism the gastric calcium increases. A loss of acidity occurs because 
the calcium is taken up by the HCl. (51) The mucous tends to neutralize 
the acid. What, then, is the mechanism of ulceration? 
Spiro divides the peptic ulcers of hyperparathyroidism into two cate-
gories based on the serum calcium level. (48) Those considered as cases 
of chromic hyperparathyroidism have serum calcium levels of 12 to 16 mg%. 
Those called acute hyperparathyroidism have higher serum calcium levels, 
around 18 mg%. Intractable duodenal ulcer is usually found in association 
with chronic parathyroid disease, but no mechanism is postulated. In acute 
hyperparathyroidism7 gastritis and achlorhydria are found and thought to 
be caused by metastatic calcification, i . e., precipitation of calcium in 
the fundic glands of the stomach. (19, 48) 
In this series of cases reviewed one case is reported in Which a duo-
denal ulcer was treated by gastrectomlf, following which a stomal ulcer 
occurred, and a jejunal ulcer was also present. (2) MUltiple adenomas of 
the parathyroids were removed at another operation, and after complete 
parathyroidectomy no further ulcers accurred. Another case of duodenal 
ulcer and stomal ulcers is reported. (7) This patient was found to have 
"adenomas" of the parathyroids but no pancreatic tumors. 
In the study of peptic ulcer in 20,000 autopsies, six of the 812 had 
evidence of disease within the parathyroids. (14) Five of these were hyper-
plasia, and one case was metastatic carcinoma. 
The histological pattern in the parathyroids when they are involved 
in polyendocrine disease is extremely ill-defined. There are several 
features to be considered in examining the parathyroids here. First, when 
there are multiple adenomas present, is only one gland involved or are 
all glands involved? Vfuile it is possible for multiple adenomas to occur 
in one gland, when hyperparathyroidism occurs in connection with polyendo-
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crine disease usually all the parathyroids are found to be involved . (57) 
Second, is the neoplastic pattern that of multiple adenomata or primary 
hyperplasia? Pathologists are divided as to Which it is. While one will 
define the pathology as multiple adenomata, another vvill define it as 
nodular hyperplasia . The division is due to the fact that neither defin-
ition is correct When applied to the morphology seen on microscopic exam-
ination of the specimens. The so-called "ademomas" are not well-defined 
encapsulated structures, and they are multiple. On the other hand, hyper-
plasia implies dif fuseness, but examination reveals small foci or nodules 
of What appears to be hyperplasia . (6) This issue is still unsettled. 
In any event, the finding of multiple foci of "adenomas" in the parathyroid 
glands should alert the clinician to the possibility of endocrine disease 
elsewhere, as well as alerting the surgeon to examine all four parathyroids 
at operation to avoid possible recurrence of hyperparathyroidism. The third 
consideration involves the cell type found . As might be anticipated, all 
cell types have been described in the "adenomas." Cope considers the mor-
phology of the tumors to be primary chief cell hyperplasia . (6) All com-
binations have been observed. Chief cell hyperplasia is the most common 
finding. (Cf. table) 
The pancreas presents some of the most interesting, intriguing, and 
confusing aspects of polyendocrine disease . Since this syndrome is charac-
terized by multiple adenomas of the endocrine glands, in the pancreas this 
leads to three possibilities with regard to cell type of the islets, as 
the histology is currently understood . (8) Generally, functioning islet 
cell adenomas may be considered either to be beta cell adenomas or non-beta 
cell adenomas. Beta cell adenomas, or insulinomas, are associated vdth 
hypoglycemia and bizarre mental symptoms . (56~ Functioning non-beta cell 
adenomas are not associated with hyperglycemia due to increased glucagon 
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secretion, as might be expected, but rather seem to be consistently asso-
ciated with a syndrome characterized by gastric hypersecretion, and peptic 
ulceration, i . e., the Zollinger-Ellison syndrome. (36) 
In the ei~ht cases studied by Underdahl, et al, five had multiple 
islet cell tumors, and two had hypoglycemia . (50) One patient had a single 
islet cell adenoma removed and continued to have hyperinsulinism. Another 
had question of hypoglycemia but no tumor was palpated at operation. Wermer 
found hyperinsulinism in three of five patients studied . (55) However, 
two of these also had ulcers. 
The first clinically recognized case of polyendocrine disease exhibited 
hyperinsulinism during the post- operative period for removal of a ureteral 
stone . (47) Same of the manifestations of his low blood sugar which ranged 
from 34 to 59 mg%, were semistupor, hemiparesis and aphasia. Another patient 
reported by Cunningham, et al , felt sensations of pins and needles in the 
legs, had periods of unconsciousness and was incontinent of urine . (9) 
Peptic ulceration also occurred in this patient . The blood sugar values 
ranged from 17 to 140 mg %. 
Cases are reported in Which the major manifestations were neurologic . 
(24, 46) One patient's history began with mental depression. (24) The 
patient later developed periods of confusion and epileptic siezures . After 
one year the patient became semicomatose with the armqand legs in a flexion 
contracture . ~ath ensued after one half year in a "psychoparalytic state . " 
Autopsy revealed, in addition to multiple endocrine adenomas, degeneration 
and loss of neurons in the cerebral cortex with satellitosis, and phago-
cytosis, an excess of glia cells, and severely affected brain stem. The 
patient's family history contained epilepsy, feeble -mindedness , cerebral 
tumors, and Cushing's disease . The author speculates that the epilepsy 
was due to central nervous system metabolic disturbance of hypoglycemia . 
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Severe hypoglycemic attacks have been reported to cause death. (46) 
The pathological anatomical features of the beta cell tumors is rel-
atively straightforward. Beta cells are easily identified by their coarse 
dark blue granules vmen stained with chrome hematoxylin and phloxine stain. 
The tumors themselves are best described as adenomatosis of the islets. 
(55) The pattern, as in the parathyroids, is hard to define, and does not 
seem to be consistent except in its extensive involvement or "multiplicity." 
The tumor(s) may be grossly palpable in the form of an adenoma, with asso-
ciated microscopic adenomas, or all the islets may demonstrate adenomatosis 
without macroscopic adenomas. (9, 24, 50, 55) 
The other tumor associated with the pancreas is the non-beta cell islet 
adenoma. In 1946, Sailer and Zinninger described a ease of massive islet 
cell tumor of the pancreas which did not present the anticipated symptoms 
and signs of hypoglycemia, but rather ulcer symptomatology. (42) A lapor-
otomy revealed a pancreat~c tumor of the delta cell type. 
It was not until 1955 that Zollinger and Ellison described an asso-
ciation between pancreatic islet cell tumors and peptic ulceration of the 
jejunum. (63) They described two cases in which marginal ulceration recurred 
until total gastrectomy was performed. In both of these patients non-beta 
cell islet adenomas were f ound. 
The symptomatology associated with this syndrome consists of severe 
burning post-prandial epigastric pain, severe intermittent diarrhea and 
weight loss. The clinical signs include hypersecretion and hyperacidity, 
and frequently ulcera in locations beyond the first part of the duodenum. 
In a study of seven patients out of 24 with these associated findings, the 
12 hour night secretion varied from 910 to 3170 cc. with only one patient 
secreting less than 1000 cc. (13) The total free HCl in five of the seven 
was greater than 100 mEq. 
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Ellison defines the location of the ulcers for all 24 cases of ulcera-
genic pancreatic tumor . (13) The age range was from 19 to 78, with 13 
females and 8 males (3 were unknown) . Nineteen had a single ulcer origin-
ally . Eleven of the ulcers were distal to the f irst part of the duodenum. 
The following distribution of 31 ulcers in 24 patients was found: 
1 eosphagus 
4 stomach 
13 first part duodenum 
6 second part duodenum 
3 third part duodenum 
4 jejunum 
The sites of 26 r ecurrent ulcers were as f ollows : 
3 esophageal 
l gastric 
ll marginal 
5 duodenal 
6 jejunal 
In their study of 812 gastroduodenal ulcers, Ellison, et al, found 
1 .1% associated with hypertrophic gastritis and there were only 8 je junal 
ulcers, 7 stomal, and 1 associated with chronic gastric perforated ulcer. 
(14) There were 26 instances of islet cell abnormality with 5 non-
beta cell islet adenomas and two cases with extreme islet cell hyperplasia. 
Interestingly, there was no multiple endocrine involvement in any of the 
cases studied . Thus, it seems reasonabl e to postulate that the ulcers 
found in the Zollinger-Ellison syndrome have features which distinguish 
them from 98% of gastro- duodenal ulcers on clinical grounds . Aspects to 
be taken into consideration include a history of intermittent diarrhea, 
severe post-prandial epigastric pain , and a few important laboratory find -
ings, especially the 12 hour overnight volume and f ree acid secretion. In 
addition , x- ray studies of the gastrointestinal tract are thought to provide 
valuable if not diagnostic features of the Zollinger-Ellison syndrome . 
X- ray studies of the gastrointestinal tract of patients with adena-
matosis of the endocrine glands shows the stomach to have a large fluid 
residuum due not to obstruction, but to hypersecretion. (45) The barium 
is not impeded. On the contrary, emptying is in the rapid range. Hyper-
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secretion is so great that gastric secretions need to be aspirated during 
contrast studies. Giant rugal folds, similar to those seen in Menetrier's 
disease, are present. These folds are not effaced when the stomach is 
distended. There are two types of glandular hypertrophy which may be seen 
in the gastric mucosa: 1) confluent adenomas that flat (giant hypertrophy 
of gastric rugae); and 2) many adenomas in the shape of polyps. The first 
type is seen in polyendocrine disease. (22) 
The gastric and duodenal ulcers have the usual appearance. However, 
the enormous size, multiplicity and unusual sites of the ulcers are con-
sidered to be significant radiologic findings. 
In the duodenum, the lumen is widened distal to the duodenal bulb, 
the mucosal folds are enlarged, coarsened, and the walls rigid. (45) In 
addition, diminished peristalsis and a retention of contrast material gives 
a picture suggesting obstruction of the distal duodenum or the proximal 
jejunum. 
The jejunum also shows coarsened folds, rigidity of the walls, and 
frequently multiple ulcerations in the region of the ligament of Treitz, 
or the segment distal to it . These ulcers often perforate and produce a 
localized peritonitis . The jejunal pattern may suggest regional enteritis. 
(53) Since the patients often have a profuse watery diarrhea, the barium 
may appear diluted due to the hypersecretion. (45) 
The authors feel that the ulcers and the fold enlargement found in 
the stomach are non-specific findings . However, if they are considered in 
conjunction with the changes in the duodenum and jejunum, then they warrant 
an investigation for endocrine adenomatosis . In summary, the changes to 
look for are dilution of barium, ulcerations throughout the duodenal loop, 
atonic megaduodenum, suggesting obstruction, marginal irregularities, and 
nodular defects due to the occasional mural location of the islet cell tumor. 
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Especially suggestive of the diagnosis are ulcers located near the liga-
ment of Treitz with a prominent rugal fold pattern and mural rigidity. 
An important symptom which is frequently described by patients found 
to have the Zollinger-Ellison syndrome is severe watery diarrhea, usually 
of many year ' s duration. Accompanying f indings are malabsonption and weight 
loss . (38) Gordon and Olivetti first described diarrhea in association 
with non-beta cell tumor in 1947 . (26) Zollinger and Craig f ound a small 
percentage of patients with non-beta cell islet adenomas to have intract-
able diarrhea. (60) This symptom preceeded the ulcers by months or years . 
The patients frequently became dehydrated and suffered large potassium 
losses. Verner and Morrison report two cases which were associated with 
intractable diarrhea and hypokalemia , (52) They postulate that there are 
two types of non-beta cell tumors . One is the alpha cell type, one the 
delta cell type, and they suggest that one produces ulceration and the 
other, diarrhea. The current evidence available does not support this 
theory . 
Since 1947, twenty- two cases of diarrhea have been reported in asso-
ciation with non-beta cell tumor . (26) Ten of these have had peptic ulcer-
ation, and nine, hypersecretion and hyperacidity . 
Zollinger, et al, found severe enteritis in 1/3 of the eases associated 
with ulcer, and in 10% of their cases it was the only symptom. (62) A 
patient presenting a history of severe and intractable watery diarrhea should 
arouse suspicion as to the presence of a non-beta cell pancreatic tumor. 
It is a serious symptom which is potentially lethal because of the meta-
bolic abnormalities it creates. 
The pathological features of the 24 cases of Zollinger-Ellison syn-
drome were evaluated by Ellison with respect to the site of the adenomas, 
multiplicity , malignancy, site of metastases, and association with other 
endocrine tumors. (13) 
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Only about 20% of the tumors were found to be non-malignant. (5/24) 
~vo of these were single, three were multiple with no section of the pan-
creas excluded from tumor involvement. Thus, about 75% of these tumors 
were classified as being malignant . (19/24) Of these 12 were described 
as single tumors, while 11/19 had metastases. 
The location of the single malignant tumors was as follows: 5 in the 
tail, 2 in the body, 4 in the haad of the pancreas, and 1 was aberrantly 
located in the wall of the stomach. Five of the 19 malignancies were des-
cribed as multiple pancreatic tumors, However, three of the five had only 
a single malignancy, whereas all five had benign adenomas present, again 
involving all sections of the pancreas . 
The sites of metastasis were variable but were confined to the region 
of the pancreas . They were located as follows: 
6 in the liver 
5 in the peripancreatic lymph nodes 
2 in the duodenum 
2 in the general peritoneal cavity . 
It is also worth noting that 4 of the 24 cases were found to have 
mixed tumors; that is, both beta cell and non-beta cell tumors identified 
on staining of histological sections . 
It has been mentioned previously that pancreatic islet cell tumors 
have been identified in polyendocrine disease. Ellison's survey shows that 
about 20% of the ulcerogenic tumors (5/24) are associated with other endo-
crine tumors . According to the definition of polyendocrine disease used 
in this paper , only three of Ellison's five patients qualify, thus making 
about 12% incidence o~multiple endocrine adenomas found in association 
with ulcerogenic pancreatic tumors . In a later paper, Zollinger, et al, 
report a 25% incidence of non-beta islet cell tumor with involvement of 
one or more endocrine glands. (62) The dis tribution of the associated 
endocrine glands was: 16 parathyroids , lJ adrenal, 9 pituitary, and 8 thy-
roid. 
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The gross and microscopic characteristics of the non-beta cell tumors 
are similar to those described for beta cell tumors previously, the major 
difference being the lack of beta granules with staining, Grossly , the 
tumors appear either as a single adenoma with microscopic adenomatosis of 
the islets, or there may be multiple small adenomas appearing as nodules. 
In the Zollinger-Ellison syndrome 15% have been microscopic only, (36) 
The cell type identified on microscopic examination shows no beta 
granules, a clear cytoplasm with nuclei which are round but larger than 
normal, without nucleoli. (42) Reliable staining is very difficult, but 
with Mallory-Azan and with Gomori stain none of the granules usually seen 
in alpha and beta cells is demonstrated , (26, 42) With the Mallory-Heiden-
hain azan dye, the cell type is identified as delta cell, which is light 
blue with dark blue granules . (59) Masson or Gomori trichrome dye shows 
a lightly basophilic to green cytoplasm, clear or with eosinophilic stip-
pling and a purple nucleus, whereas the alpha cell is red and the beta cell 
is dark blue. The adenomas are composed of broad sheets of uniform cell 
type, considered to be delta cells, which are separated by connective 
tissue trabeculae . The vascular supply is rich and r osettes often appear 
around the capillaries. (42, 58) The so- called ribbon pattern, seen also 
with the carcinoid syndrome, is the descriptive term for these sheets of 
cells . (59 ,62) 
Very often all the islets are seen to be involved microscopically . 
The poor surgical results obtained i~~reating patients with Zollinger-
Ellison type ulcers may be due to hyperplasia of all the islets . (61) This 
is thought to account for the intractability of the ulcers, and in addition 
implies that normal islets have an endocrine influence on gastric function . 
Whereas in the Zollinger-Ellison syndrome a pure cell type is found on exam-
-( ~<t.U~-611fi.h. 
ination, in the polyglandular syndrome the adenomas~co~tain-~ mixture of 
all cell types. (60) 
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The identification of non-beta cell islet tumors in association with 
fulminating peptic ulcer can't avoid raising the issue that peptic ulcer 
is an endocrine disease. Opinions vary widely· as to whether a specific 
islet cell type secretes a gastric stimulating hormone . Evidence for 
secretion of such a pancreatic hormone in normal individuals is scant. (32) 
Specific proof of this is ttill not sufficient to settle the issue. How-
ever, there is some convincing evidence that the pancreatic islets eo 
secrete the unidentifieo hormone in the Zollinger-Ellison syndrome. Con-
firmation of this proposed mechanism of peptic ulceration is essentially 
awaiting reproducible results and the isolation and identification of the 
hormone to make the observations valid. 
Keynes claims that removal of a pancreatic tumor will not affect 
gastric secretion because the Zollinger-Ellison syndrome is part of a larger 
hypothalamic endocrine syndrome, and that damage to the hypothalamus pro-
duces Zollinger-Ellison type tumors . (23) Others have provided experimen-
tal evidence that removal of pancreatic tumors will affect gastric secretory 
function . Vagotomy and antrectomy fail t o control the ulcer diathesis in 
these patients. (18, 59) 
Because of the histological similarity of the tumors to carcinoid, 
serotonin has been suspected to be the agent responsible for the syndrome . 
(60) However, experiments show that gastric secretion is not stimulated 
with serotonin. (62) Moreover, serotonin breakdown products are not inc-
reased in the urine of patients with the syndrome . 
Confusion in the identification of the cell type has led to postulation 
of either glucagon or insulin as the ulcerogenic agent. Insulin has been 
disqualified by lack of increased gastric secretion in patients with known 
beta cell tumors. (63) Only two cases of ulcer with beta cell tumor were 
found by Zollinger and Ellison . 
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Zollinger and Ellison provided evidence that glucagon might be the 
unknown factor. (6J) They studied the serum of a patient who had an ulcero-
genic malignancy . By electrophoresis they found an abnormal fraction in 
this serum. Purified glucagon mixed to serum gave the same electrophoretic 
pattern. Six fractions were eluted from the serum and assayed in anesthe-
tized cats. Fractions 5 and 6 produced elevated blood sugars, supporting 
their theory . Unfortunately, this finding has never been repeated, or 
duplicated by any other investigator . Other experiments have indicated 
that glucagon decreases gastric secretion and motility. (60) 
More convincing evidence of a pancreatic hormone has been demonstrated 
by experiments using actual tumor tissue extracts. Gregory, et al, used 
a tumor demonstrating islet cell neoplasm microscopically, which was removed 
from a patient with duodenal ulce~, esophagitis, and steatorrhea . (21) 
They homogenized part of the tumor in Tyrodes solution and infused it into 
anesthetized rats and a Heidenhain pouch dog. With this preparation there 
was no evidence of gastric stimulation. 
On the contrary, when they prepared another part of the tumor in a 
manner similar to that used for preparation of gastrin from hog antral 
mucosa, different results were obtained. The tissue was minced with moist 
picric acid crystals, then extracted with an excess of acid aqueous acetone, 
precipitated and washed with trichloroacetic acid, and inert protein removed. 
The final solutiun vvt:..~ ..: ..... ear w~ th pH 8. 2 in 0. 9% NaCl solution. When this 
solution was injected subcutaneously into a fasting, conscious dog with 
a denervated Heidenhain pouch, a large and prolonged secretory response 
occurred w.i.. ~n.J..n r·u ·teen minutes . Pepsin secretion was not stimulated . 
Compared to the response obtained from an equal weight of hog antral mucosa, 
the response of the tumor extract was 45 t imes greater. To rule out insulin 
as the factor, they found that subcutaneous insulin stimulated acid and 
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pepsin secretion from the main stomach, but none from the Heidenhain pouch. 
Histamine activity of the homogenate was found to be negligible. 
In a similar type of experiment, Osborne, Brown, and LeCompte homog-
enized a sample of human non-beta cell islet carcinoma, anu ...:ulll!Ja.L'ed their 
results with those obtained with similar e.x.t.L'al:tS of human liver and normal 
pancreas . (31) The first sample was prepared by homogenizing and tritura-
tion into normal saline, then dialyzing against 40 cc. of saline for 48 
hours at 4°C. The second sample was dialyzed for 24 hours against 30 cc. 
of saline . Both the dialysates and r esiduums were tested on dogs with 
Heidenhain gastric pouches. The dialysates were injected intravenously. 
The residuums were centrifuged and supernatant fluids used for testing. 
Simultaneous blood sugars and pouch samplings weee collected. Their results 
were as follows: 
SAMPLE 
Dialysate A 
nel:>iduum A 
Dialysate B 
Residuum B 
:rill 
7.2-1 . 72 
8 . 3-7.5 
7 .0-4.3 
8 . 4-4.1-1 . 6-1.5-7 . 4-2 .6 
BLOOD SUGAR (mg%) 
81- 92 
70,90,82 
72,--,74,77,99,~4 
rrom their results they concluded that the factor is water soluble, has 
a molecular weight of less than 25,000, since it traverses the cellophane 
membrane, resists post-mortem autolysis, acts quickly to cause acie secre-
tion, and does not resemble insulin or glucagom. 
Another method of extraction was used by Matthews, et al, on tissue 
from a patient that died of severe electrolyte disturbances resulting from 
chronic diarrhea. (26) Autopsy revealed metastatic islet cell carcinoma 
of the islets. The tumor was extracted with saline, acid ethyl alcohol, 
and made to pH 8 .0 with a~ueous ammonia and then given intravenously to 
conscious fasted dogs . The stomach and small intestinal contents were 
collected separately for six hours . Their tumor extracts were compared 
to an extract of metastases, and to normal pancreas. The results obtained 
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were variable but, in general , consistent with the results of Osborne and 
of Gregory . The volume of gastric secretions ranged from 1 . 23 to 17 times 
the control. Pepsin showed no consistent change while free and total acids 
were increased in f our out of five dogs . The metastases showed no con-
sistent change . The normal pancreas did not stimulate gastric or pan-
creatic secretions . They concluded that the pancreatic agent resembles 
gastrin, stimulates acid but not pepsin secretion . 
Freisen, Tracy , and Gregory prepared extracts of metastatic lymph 
nodes and liver in the same manner as reported above by Gregory, and tested 
them against the primary extract on the same dogs used earlier . (18) They 
reported similar responses (i . e . , acid secretion) from all three extracts, 
the response varying mainly in duration . So, for the first time functional 
activity was demonstrated in a metastasi s . 
Zollinger, et al, studied the effects of extracts from five tumors 
and two metastases o~ Pavlov pouch dogs . (62) The results from both the 
tumors and the metastases showed a curve that was the same as that for 
gastrin extracted from antral mucosa . Evidence for a gastric secretagogue 
was not evident in extracts of the parathyroids , thyroid, adrenal or car-
cinoid tumor . 
In an effort to clarify the role of the pancreas in normal gastric 
function, Osborne, Pernokas, and Brown studied the effects of pancreatic 
extracts of both dogs and humans , using extraction methods of Gregory and 
Tracy . (32) They observed that normal dog and human pancreas did not pro-
duce a secretagogue . However, an active secretagogue was demonstrated with 
a sample taken from a patient with intractable duodenal ulcer . 
An extraction method specific for polypeptides was then used and 25 
seemingly normal pancreatic samples were tested. Of these , three were f ound 
to be active . One was associated with the duodenal ulcer cited above , one 
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with a chronic gastric ulcer, and one with diverticulitis but not ulcer. 
These samples were then analyzed for peptides with ninhydrin and demonstra-
ted a much higher amount of peptide than the remaining samples. They also 
obtained the secretagogue from the parotid gland of a patient without 
ulcers. 
They conclude that the substance is not similar to gastrin because 
it is non-protein as evidenced by injection into protein sensitized dogs 
without any anaphylaxis, and by their method of extraction. Gastrin, as 
defined by Wadell, is a protein lacking species specificity. This report 
does not substantiate the current evidence that the pancreatic principle 
is gastrin, and raises new issues in the understanding of the Zollinger-
Ellison syndrome, 
In the discussion of the roentgenological appearance of the gastro-
intestinal tract in Zollinger-Ellison syndrome, it was emphasized that 
giant rugal folds, similar to those seen in Menetrier's disease are frequently 
seen . However , gross and microscopic examination of the stomach in the 
Zollinger-Ellison syndrome shows actual thickening of the mucosa and an 
increase in the number of parietal cells. (18) The hyperplasia of the 
gastric glands may also include the pylorus . In contrast, Menetrier's 
disease has a normal pattern and cellular detail with an elongation of the 
gastric glands , 
In summary, the experimental evidence, while not yet conclusive, indi-
cates a hormonal relationship between the islets of Langerhans and acid 
secretion of the stomach, In the Zollinger-Ellison Sj~drome, a hormone 
which acts biologically like gastrin , is produced caasing hyperplasia of 
parietal cells and gives rise to the clinical findings of hypersecretion, 
intractable ulceration, giant rugal folds, ulceration in abnormal locations, 
i . e . , at the ligament of Treitz . 
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This concept also helps to explain the refractoriness of the diarrhea 
and the ulcers to surgical removal of the non- beta cell tumor . Three fac -
tors must be considered in the explanation . First, the microscopic feat -
ures of the pancreas indicate that frequently all the islets are hyper-
plastic, thus removal of a single adenoma does not diminish the "hormone" 
sufficiently to control gastric stimulation . In addition, the high inci-
dence of malignancy and the evidence for functioning metastases provides 
another source of gastric stimulation . Moreover, since stimulation con-
tinues, partial gastrectomy will not prevent recurrent ulceration because 
the remaining pari etal cells are still being stimulated to secrete HCl . 
It is for this reason that total gastrectomy is recommended as the procedure 
of choice in the treatment of the Zollinger-Ellison syndrome . (59) 
The evidence in support of ulcer ogenic tumors of the pancreas is quite 
convincing . However, until the hormone is isolated and identified, the 
evidence must rest with the finding of refractory ulceration or diarrhea 
in association with a non-beta cell pancreatic tumor. If one accepts this 
theory, then the question that arises in considering ulceration in poly-
endocrine disease is whether or not it is the non-beta cell adenomas which 
cause the ulcers . While most authors seem to accept the idea that Zollinger-
Ellison syndrome may be a part of polyendocrine disease, (3, 54) There is 
a report which finds convincing evidence lacking. (JO) The report describes 
eight cases of non-beta cell adenomas , six of which contained the tumor 
within the wall of the second porti on of the duodenum only, without aden-
omata within the pancreas proper . All six were males, ranging in age from 
41 to 78 years . They all had ulcers with a high recurrence r ate, typical 
of the Zollinger-Ellison syndrome, and secreted more than 100 mEq/12 hr . 
It should be emphasized, however, that the islets did show proliferation 
and hyperplasia. As described earlier, the pancreatic tumors have only 
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microscopic involvement of the pancreas very often, and, at best, the dis-
tinction between adenomas and hyperplasia is ill-defined . They also found 
two cases of multiple endocrine adenomas with non-beta cell tumors in the 
pancreas proper . Because in these cases there are proven adenomata of other 
endocrine organs, they feel unjustified in implicating the pancreatic tumor 
as the cause of ulceration . They do, however, agree with others that the 
presence of Zollinger-Ellison type of ulceration and the presence of a 
pancreatic tumor warrants careful investigation of other endocrine organs . 
OTHER ORGAN SYSTEMS 
Pathological findings are not limited merely to the pituitary, para-
t~£oids, and pancreas . Frequently the adrenal cortex contains hyperplasia, 
either f ocal nodular, (15, 27, 33, 50) or diffuse, (4, 7, 9, 40, 43) or 
multiple adenomas (13, 27, 36, 64) . Few single adenomas are found . (1, 
13, 50) Cf . chart 
Once again the question of an ulcerogenic role is raised , Ellison's 
sur vey of ulcers found at autopsy showed 13 . 2% to be associated with adrenal 
hyperplasia, whereas the incidence of adrenal hyperplasia in the 20,000 
cases examined was found to be 5,6% . (14) From these statistics they con-
eluded that the adrenal cortex is an important factor in the production 
of peptic ulcer. 
In the group of 33 cases found by Zollinger, et al, to have endocrine 
involvement other than in the pancreas, 13 were found to have adrenal 
involvement, or about 40%. (62) 
The problem in evaluating adrenal involvement in multiple endocrine 
adenomas is whether the involvement is primary or secondary to pituitary 
involvement . Bilateral hyperplasia of the adrenal cortex, expecially of 
the zona fasciculata is associated with basophilic adenomas of the pituitary, 
(56) However these adenomas often are not associated with hyperfunction } 
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of the adrenal cortex. On the other hand, chromophobe adenomas cause des-
truction of the sella and can produce Cushing's disease . (56) The adrenal 
pathology has also been postulated to result from an effort to maintain 
the blood sugar by glycogenolysis, thus making it secondary to a pan-
creatic insulimoma. When the blood sugar falls below 70 mg%, secretion 
of gastric juice is stimulated by insulin . (9) It is not in the scope of 
this paper to explore adrenal manifestations more than to the extent that 
they might play a role in ulcer production when present with the concomi-
tant finding of multiple endocrine adenomas . 
The thyroid is occasionally involved in polyendocrine disease, although 
not as strikingly as is the adrenal. One case reports multiple follicular 
adenomas . (36) The other reports indicate a single nodule (l) or cyst 
(50). The significance of thyroid pathology may be only a coincidental 
finding, or an effect secondary to a pituitary lesion . However, it had 
not been implicated in the pathogenesis of ulcers . Ellison, et al, found 
eight patients with thyroid involvement in association with JJ non-beta 
cell pancreatic tumors. (14) 
Another not infrequent finding in patients found to have multiple endo-
crine adenomas is the presence of disorders related to the gonads . Multiple 
ovarian cysts, testicular atrophy , loss of libido, late menarche, or primary 
amenorrhea is often present . (7, 15, 64) Again these effects may be coinci-
dental findings, or secondary to altered pituitary function . 
The clinical diagnosis of polyendocrine disease rests in demonstration 
of involvement of the pituitary, parathyroids, and pancreas . The presence 
of gastrointestinal ulcers in association with involvement of one of these 
glands warrants examination of the other two organs because of the degree 
of association between peptic ulcers and polyendocrine disease . 
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ETIOLOGY 
Several theories regarding the etiology of multiple endocrine adenomas 
have been postulat ed , but all remain unproved to date . In general, there 
is a division in thought regarding the origin of peptic ulcer in the syn-
drome which accounts for the diversity of etiologies suggested . On the 
one hand, the gastrointestinal pathology is considered to be a secondary 
manifestation of endocrine disease, while on the other hand it is regarded 
as a part of the same defect which produces the defects in the endocrine 
organs . 
Russfield, et al , suggest "end organ failure" as the origin of the 
pathway beginning, e .g., with hypogonadism or hypothyroidism, and ultimately 
leading to peptic ulcer due to generalized endocrine hypersecretion . via 
pituitary stimulation . (41) There are two immediate objections to this 
theory. First is the absence of hypogonadism or hypothyroidism in al l or 
most of the cases of polyendocrine disease . Second , is the lack of evidence 
of pituitary trophic hormones to both the parathyroids and the pancreas . 
SCHEMA 
hypogonadism 
~I 
amphophilic pitui t ary adenoma 
pitui~ry trophic hormones 
~ 
endocrine adenomatosis 
endoctkne hypersecretion 
-V peptic ulcer 
Some authors regard the antrum of the stomach as a true endocrine 
organ . Rudolf , Dammin, and Moore support the theory of "end organ failure" 
as the cause for stimulation of the pituitary trophic hormones, but hypo-
thesize that the parietal cell hyperplasia arises as a direct result of 
stimulation of the pituitary- antral axis . (40) They offer experimental 
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evidence that hypophysectomy of animals will lead to involution of the 
chief cells and depletion of pepsinogen granules . While these observations 
may be true, they cannot conclude that the converse, an increase in the 
output o~ituitary trophic hormones, will caase hypersecretion of pepsin . 
Moreover, peptic ulcers in the Zollinger-Ell ison syndrome are associated 
with hypersecretion of acid and not the pepsin fraction . Also, t he same 
obj ections t o Russ f ield 's theory apply here . 
Another sequence was suggest ed by Moldawer , Nardi, and Raker based 
on their observation of the coincidental condition of acromegaly and para-
thyroid adenoma . Both of these conditions are related to phosphorus metab-
olism . (28) In addition, the pancreas also plays a role in determining 
the serum phosphorus l evel . Gl ucose and insulin produce a decreased serum 
phosphorus level . Their own objection to this proposed sequence was the 
occurrence of non- eosinophilic pituitary adenomas in association with 
parathyroid adenomas . 
SCHEMA 
increased growth hormone-------acromegaly 
increased s~rum phosphorus 
decreased serum ca~ium----------parathyroid hyperplasia 
adenoma f ormation 
and 
The frequent observation of familial incidence of multiple endocrine 
adenomas forms the basis for the theory of a genetic origin of polyendocrine 
disease. Wermer was the first to make this observation , and his theory 
is one the most plausible suggested , (55) It remains unproved, however . 
A family was studied in which four of nine siblings were affected, 
and both sexes were involved , Fvom this distribution , Wermer concluded 
that a single gene is involved, and that it must be an autosomal dominant, 
since it is unlikely that non- consanguinous parents would carry the same 
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rare gene . Wermer also postulates that the gastrointestinal lesions are 
another manifestation of the abnormal gene because the pituitary, para-
thyroids, pancreas, stomach , and duodenum develop in the embryo at four 
to five weeks . (J9, 64) 
The literature is extremely confusing with regard to family history, 
and it would be difficult to draw any conclusion from case reports which 
state only that the grandmother had "an ulcer . " In their JJ cases of con-
comitant non-beta cell tumor and endocrine gland involvement, Zollinger , 
et a~ , found 15 to have a definite familial tendency . (62) 
Moldawer, et al, agree that the genetic evidence is the most convin-
cing, and speculate that if two glands are involved than the third gland 
will eventually be involved if the cause is a single defective gene . (28) 
They regard the presence of multiple adenomas as a significant f inding in 
this syndrome in contrast to the single adenoma found with single organ 
involvement . 
The evidence for a genetic basis f or polyendocrine disease is supported 
by the many instances of familial involvement reported in the literature . 
While the genetic theory may be true, the question of peptic ulcer in this 
disease still remains an unsolved mystery , Wermer believes that gastro-
intestinal lesions are due to the defective gene . Other authors feel that 
peptic ulcer, and in particular , t he Zollinger-Ellison syndrome is one 
expression of polyendocrine disease , (J , 27) Frame, et al, report a family 
with polyendocrine disease in ten members spread out over four generations 
and conclude that the defect is transmitted by an autosomal dominant gene 
with a high degree of penetrance , (27) 
Vfhile it seems reasonable to conclude that Zollinger-Ellison syndrome 
can arise anew as any neoplasm can, the view has al so been expressed that 
Zollinger-Ellison syndrome and multiple endocrine adenomas arise from the 
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same defective gene, because of the high association between the two enti-
ties. (46) Manifestations of the Zollinger-Ellison syndrome occurring 
without any associated endocrine adenomas are considered to be a normal 
penetrance of the gene, but only a partial expressivity of it. With full 
expressivity multiple endocrine adenomas would be present. 
SUM!\iffi.RY 
The potential for the development of a variety of combinations of 
diseases and their complications resulting from multiple endocrine adeno-
mata is seemingly infinite . There is no specific pattern to the clinical 
manifestations of adenomas involving the pituitary, parathyroids, pancreas, 
and frequently other endocrine organs . Recognition and diagnosis of poly-
endocrine disease is made difficult because of the lack of a common denom-
inator. The one disorder that appears most consistently in patients with 
multiple endocrine adenomata is peptic ulcer . The concomitance of peptic 
ulcer and disease in an endocrine gland warrants an evaluation of the other 
endocrine glands . 
Peptic ulcer also presents in a variety of ways, Certain character-
istics of the peptic ulcer may suggest the diseased endocrine organ. Pit-
uitary tumors are implicated as a cause of peptic ulcer, but there is no 
--fufY7oo, 
particular characteristic to suggest the presence of a pituitary 1, Para-
thyroid tumors, likewise, are implicated as a cause of peptic ulcer . The 
correlation is thought to be significant . ~vo types of ulceration are 
described in association with parathyroid tumors. Chronic duodenal ulcers, 
frequently reversed by parathyroid surgery, are more commonly found. Acute 
hyperparathyroidism with very high serum calcium levels is aasociated with 
metastatic calcification in the fundic glands of the stomach resulting in 
gastritis and achlorhydria . This feature of peptic ulceration serves to 
distinguish acute from chronic hyperparathyroidism. 
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The pancreas is considered as the cause of the most characteristic 
type of peptic ulceration. Non-beta cell tumors of the islets cause huge 
amounts of gastric secretion, especially the acid fraction, and ulceration 
in more distal locations than is seen in the usual case of peptic ulcer. 
There is evidence for a gastric stimulating hormone from the pancreas, 
which may only be present in disease, and not in the normal pancreas. X-ray 
studies of the gastrointestinal tract show pathognomiDnic features such as; 
diluted barium ulcers near the ligament of Treitz, amd in the jejunum, 
atonic megaduodenum, enlarged folds in the stomach, and nodular defects. 
Beta cell tumors have not been directly associated with peptic ulcer. 
However, it should be remembered that gastric stimulation occurs when the 
blood sugar falls below 70 mg%. The role of the adrenals in the formation 
of peptic ulcer has not been established. 
The question of the etiology of polyendocrine disease is still unan-
swered. The genetic theory of an autosomal dominant defective gene, postu-
lated by Wermer, seems to be the most acceptable explanation so far. Even 
though many accept this theory, the prevailing concepts are divided on the 
issue of the pathogenesis of peptic ulcer in polyendocrine disease. Some 
feel that peptic ulcer is the result of a single genetic defect. Partial 
expressiviey produces the Zollinger-Ellison syndrome, while full penetrance 
of this single defective gene causes both peptic ulcer and polyendocrine 
disease. Others regard peptic ulcer as a secondary manifestation of endo-
crine disease, and only the adenomas of the pituitary, parathyroids, pan-
creas, and possibly the adrenals result from the genetic defect. 
COMMENT 
The manifestations of peptic ulcer in the presence of polyendocrine 
disease are so variable that it would seem more plausible to consider it 
as an effect secondary to disease in the endocrine system . Tpe correlation 
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of peptic ulcer with pituit ary and parathyroid tumors, as well as with 
pancreatic tumors, suggests that this is the mechanism. The etiology of 
the Zollinger-Ellison syndrome must be considered separately . While the 
explanation that the Zollinger-Ellison syndrome is a partial expressivity 
of a genetic defect is plausible , the data to date does not verify a gene-
tic basis for the disease, which may, however, have a familial tendency . 
From this review of the subject, it seems more reasonable to regard poly-
endocrine disease as the result of a genetic defect which can manifest 
itself in an array of disorders, one of the most common being peptic ulcer . 
Each cell type or , more often, mixtures of cell types may undergo adeno-
matous development . The Zollinger-Ellison syndrome can be considered to 
arise either as a single adenoma of the non-beta cells of the islets, in 
a manner similar to that for single adenomas elsewhere, or it can be one 
of the manifestations of polyendocrine disease, in which the non-beta 
islet cells become adenomatous and as an end result cause peptic ulceration. 
In that event, peptic ulcer is a complication of disease of the endocrine 
system . The characteristics of the peptic ulcer, and the response to 
corrective therapy, may be a clue to the organ which is di seased if peptic 
ulcer is regarded as a complication secondary to disordered endocrine 
function. 
CASE REPORTS 
Summary of important findings : 
REFERENCE PT . AGE SEX PITUITARY PARATHYROIDS 
------------~---------.------r-----.-----.-----------------------r-----------------------r-----· 
Basian and Zeifer(l) 1 l l 1 I Bilateral staghorm 1 
l l I l I calculi. l 
I I I I I Adenomas of inf . para- I 
I I I I 1
1 
thyroids 11 I I I I 
I I I I I I 
I I I I I I -----------~---------+------:------~-----~-----------------------r-----------------------1 
Cassidy and Anderson IR.D. I I I ! Bi l ateral r enal calculil 
(2) I I l I 12 adenomas: chief and I 
I I 1 I I oxyphile cells I ---------------------t------r-----~-----r-----------------------~-----------------------1 
" lR.A.D.f I M I I Adenomas- 4 glands: I ! I i I !chief and oxyphile cellf 
I I I I I I ----------~---------t------r-----r-----r-----------------------~-----------------------~ 
11 IC.D. I I F I !Renal disease; 6 adeno-1 
I l l I fmas, chief and oxyphilel 
---------------------t------r-----r-----r-----------------------~-----------------------1 
Cooke, et al (4) I l40 IF IJ microscppic chromo- !Renal colic, staghorn I 
I I I I phobe adenomas I calculus , demineraliza-1 
I J I I l tion spine ~ J parathyroi~ 
I 1 I I ltumore, clear cells I I I I I lwith oxyphiles J 
---------------------+------~-----~-----~-----------------------}-----------------------· I I I I I I I I I I I 
Cope, et al (7) 1#147 122 IF I (Small kidney stones I 
1 I I I (1° chief cell hyperplasi a ---------------------4------t-----~----~-----------------------}-----------------------~ 
" 1#148 I 1M I Enlarged sella turcica I Bones decalcified l I I I I "Adenomas 11 
I I I I I I I I I 
I I I I I I I I ---------------------T------~-----}-----~-----------------------~-----------------------
11 1#170 l I I Chromophobe adenoma I Hyperplasia 
I I I I I 
I I I I 11 I I I 
_ I I I I I ----------~---------~------r-----r-----~----------------------~-----------------------1 
11 11#197 I I I !Hyperplasia I 
I I I I I I I I I I 
I I I I I I I I I I I 
l I I I I I 
---------------------~------~-----~-----~-----------------------~-----------------------~-Cunningham, Hawe , and l 142 IM !Grossly normal !Kidney stone I 
Evans (9) 1 I I I I I 
I I I I I I I I I I I 
l I l I I I 
---------·-----------~------~-----~-----~-----------------------~--------------~-------1 
Eiseman and Maynard lN.W. 139 IM !Erosion of sella !Renal calculii adenoma 
( 12) l I l I I 
I I I I I I I I I 
I I I I I 
I I I I I 
I I I I I 
---------a-----------~------~-----~-----~-----------------------~-----------------------1 I I I I 
I I I I I 
I I I I I 
I I I I I 
I I I I I 
I I I I I 
I I I I I 
I I I I 
PANCREAS G.I. TRACT OTHER 
SIGNIFICANT 
FAMILY HISTORY 
r-----------------------~-----------------------~--------------------~L---------------
INon-beta cell islet 12 large gastric ulcers !Adrenal cortical !two children wi 
I carcinoma ltumor on lesser curva- ladenomai para-aortic !duodenal ulcer 
I I ture, serosal I lymph node; liver 1 
I l gastro- jejunal ulcer !metastases; thyroid 1 
I I ln~ule 1
1 1 I I ~-----------------------r-----------------------~---------------------L---------------1 I I I 
1 I I 
1 I I 
1 I I 
I I I 
I I I 
I I I -----------------------~-----------------------+---------------------~---------------1 I I 
1 I I 
I I I 
1 I I 
I I I 
I I I 
I I I ~-----------------------~-----------------------~---------------------~---------------( !Duodenal ulcer, stomal !Simple goitre !Mother of R. D. 
1 I ulcer, jejunal ulcer 1
1 
!Sister of R.A.D 
I I ~-----------------------1-----------------------~---------------------~---------------
lsmall islet cell 1Ulcer-2nd part duodenumjAdrenal hyperplasia 
ltumors lstomach mucosa thickene~Fatty change in the 
I land mammillated with !liver 
I !inflammation and indur-1 
l 1ation of wall of duo- 1 
I ldenum and jejunum 1
1 I I 1-----------------------~-----------------------~---------------------J ______________ _ 1 I I I !HYPoglycemia 1 1 IJ)aughter of #14 
12 islet cell tumors ! l I 
l-----------------------~-----------------------1---------------------1---------------
lc,nvulsion lDuodenal ulcer, stomal !Thyroid adenoma with !Father of #147 
I hlcers ~erplasia ~other and one 
l l 1 [brother-peptic 1 I I I ler 
l-----------------------4-----------------------~--------------------1---------------· 
I I IT
1
1 
hyroid metaplasia 1 
I I 
1 1 land adenoma; adrenal l ! i ~Cortical hyperplasia 1 
~----------------------~----------------------;---------------------1r--------------· ~on-beta cell islet buoeenal ulcer, gastrit~ l 
b.denoma puodenitis, 4 jejunal 1 I 
I p1cers, jejunitis . 1 I 
I ro hypersecretion 1 I L----------------------i!----------------------1r--------------------~--------------· ~ypoglycemia. Lipomata,~yperacidity. Ulcer 1st ~drenal cortical aden4 
cyst, cystic adenoma, 2 ~nd 2nd parts duodenum pma; bilateral hyper- I ~denomata . p perforations jejunum ~rophy of cortex and I 
1 I Jnedulla I 
r-----------------------r----------------------~---------------------~--------------· ~ypoglycemia . J islet fersistent peptic ulcer l I 
pell adenomas; carcinoma~st part duodenum and l l 
1 flistal to gastrojejunos -1 I 
I ~omy l I 
r-----------------------r-----------------------~---------------------~--------------· 
I I I I 1 I I 
1 I I I 
1 I I I 
1 I I I 
1 I I I 
1 I I I 
I I I I 
REFERENCE PT . AGE SEX PITUITARY PARATHYROIDS 
----------------------r----~-----~-----~-----------------------,-----------------------,---~--· 
Ellison (1.3) IF .Y. tsl 1 M 1 1 - I 
I I I I I I 
I I I I I I 
I I I I I I 
I I I I I I 
----------------------L----~----~-----~----------------------~----------------------~ 
- I I I I I I 
" I L . p . I 76 I M 1- I I 
" I I I I I I I I I I I 
I I I I I I 
______________________ l ____ j _____ J _____ JL _______________________ ~ ______________________ J 
- I I I I I I 
" 1 C. H. I' 57 1 F II Basophilic adenoma 1 1 
I I I I 
I I I I I I 
I I I I I I I I I I I 
I I I I I I 
I I I I I I 
----------------------t----~-----~-----1-----------------------;-----------------------; 
" I F H I 55 I M I I I I • • I I I I I I I I I I 
I I I I I I 
I I I I I I 
I I I I _ I I 
I I I I I I 
----------------------t----i-----l-----~-----------------------~----------------------~ 
" I I 75 I M I I I I I I I I 
I I I I I I 
I I I I I I 
I I I I I I 
I I I I I I 
---=------------------t----~-----~-----~-----------------------~-----------------------~ 
Fisher and Flandreau I J . E. I a7 I M I Increased amphophiles; I Renal stones; all cell I 
(15) IR· I 1 I hypertrophic amphophil1 types , nodular and 1 
1 II 1 1 and basophiles . 1 enlarges 1 
I I I I I I I I I 1 ----------------------t----~-----~-----~-----------------------~-----------------------1 
Franks son , et al (17) 1 l f 1 I Bilateral ureteral 1 
1 1 I 1 I calculi ~ generalized 1 I I I I 1 decalcification; 4 1 
1 I I I 1° chief cell hyperpl . 1 ----------------------t----~-----~-----~-----------------------~-----------------------~ 
Kramore and Makkink 1 I 1 I Chromophobe adenoma 1 Nephrocalcinosis 1 
(24) 1 I 1 I I Adenoma 1 
I I I I II I 
I I I I I --~-------------------~----i-----i-----~-----------------------1-----------------------i 
Lloyd ( 25) I I 22 1 F I Temporal quadrant 1 Mul t . tumor- like f I I 1 I field defects ; chromo-1 nodules 1 I I I I phobe adenoma 1 1 
----------------------r----i-----i-----i-----------------------4-----------------------i 
Frame, et al 1 I 46 I F I I 1 °chief cell hyper- I 
1 I I I I plasia I I I I I I I 
I I I I I I ----------------------~----~-----~-----i-----------------------i-----------------------i 
" I 5.3 F 1 Amphophi l ic and baso- 1° chief cell hyper-
1 philic hyperplasia plasia 
I and microadenoma 
I 
PANCREAS G.I. TRACT OTHER 
SIGNIFICANT 
FAMILY HISTORY 
- 2 
· -----------------------r-----------------------~-------------------~----------------
Islet cell carcinoma !Duodenal ulcer I ! 
and aaenomatous hyper- I I 1 
plasia I I •, 
I I -----------------------r-----------------------~-------------------~----------------
Islet cell carcinoma I Perforated duodenal I Liver metastases ! 
!ulcer; dilated small I 1 
lbowel with fluid levels l •, 
I I -----------------------T-----------------------+-------------------~-------------...--
Adenocarcinoma !Diarrhea , hypermotility iLiver metastases ! 
Diabetes !Prominent gastric rugae l 1 
lstomal ulcer , 2 duodenal 1 
!ulcers I •, 
I I -----------------------T-----------------------+-------------------~----------------
Islet cell carcinoma !Hypertrophic gastritis ILymph node metas- I 
!Ulcer- 2nd part duodenum ltases in peritoneal ! 
!Duodenal metastasis lcavity, gastro- 1 
I lhepatic ligament •1 I I -----------------------~-----------------------·-------------------~----------------1 I I Islet- cell adenomata tDuodenal ulcer 1 I 
with malignant changes !Atrophic gast r i tis 1 1 
Pancreatitis l l l 
-----------------------J-----------------------·-------------------~----------------
Non- beta cell i slet !Diarrhea , Ulcers in INodular hyperplasia •,' 
I I 
adenomas; diabetes t2nd part duodenum, ter-l adrenals l 
lminal duodenum, proximalAtrophy of testes 1 
lJ· ejunum 1 1 
I I I -----------------------~-----------------------~-------------------~----------------· I I I INon- beta cell tumor; tDuodenal ulcer , stomal 1 1 Father- peptic 
1hyperplasia and adeno- lulcer , inc . parietal l 1 ulcer 
lmata; 2 cell types !cells l l 
I I I I l I I I ·-----------------------~-----------------------~-------------------~----------------· I "Psychoparalytic state" I ~drenal hyperplasia I Father-Cushing' 
ihPPoglycemia . Beta-eel~ 1
1
zona fasciculata 1 
1nodules , islet cell I 1 1 
J adenomas . I I 1 
·-----------------------~-----------------------~------------------~----------------· IMul tiple t umor- like I ~anarche at 19 
1
1 
lnodules ! !Numerous ovarian 1 I 1 !cysts l 1-----------------------j_ ______________________ j _____ ______________ J _______________ _ , 
iislet cell carcinoma ~ypersecretion , refrac - ribroids , lipoma; fister of nest Cc 
1 ttory duodenal ulcer, p.ymph nodes near 1 
1 ~rominent rugal folds, jhead of pancreas . l 
·1-----------------------~arietal cell hyperplas~~------------------4----------------· p islet cell tumors wit~iarrhea lfibroids , bilateral !Peptic ulcer-nepl 
!hyperplasia and micro- puodenal ulcer ~drosalpinx, nodu- ~slet cell and ac 
!adenomatosis ~ar hyperplasia of pal adenomas- sisi 
l !adrenal cortices t<idney stomes-blOc 
I ~yperparathy . -nej 
I ~Perforated peptic 
l lucer, mul t . adre 
I ~denomas , nephroc 
I binosis - sister 
1 .Hype:roarathy . - so!l I }ieptic ulcer-daug 
I Hyperparathy.-fat 
I I 
I I 
I l 
REFERENCE PT . AGE SEX PITUITARY PARATHYROIDS 
---------------------,-----lr----lr----.-----------------------.------------------------~--~--· 
Pearl , et al ( 33) 1 1 33 1 M l (mild degree) Acido- 1 Generalized osteoporosi~ 
I l 1 1 philic hyperplasia l Chief cell adenoma 1 ---------------------J-----~----~----~----------------------~-----------------------1 - I I I I I I
Pender (34) I I I I I 11 
I I I I I 
I I I I I I 
I I I I I I 
I I I I I I 
---------------------~----~----~----~----------------------~-----------------------1 ~ I I I I I I
Potter and Sabesmn I 1 1 1 Eosinophilic and chrom;Adenoma and hyper- 1 (36) 1 1 1 1 ophobic adenoma 1 plasia 1 
I I I I I I 
I I I I I I 
--~------------------1-----1-----;-----;-----------------------;------------------------l 
Rawson, et al (38) I I 55 I M I I I 
I I I I I I 
I I I I I I 
t I I I I I I I I I I 
--~------------------1-----1r----~----~----------------------~-----------------------l 
Moore , et al ( 40) I I I I Amphophilic hyper- I 1 
1 I 1 I plasia 1 1 
I II I I I I 
I I I I I 
I I I I I I 
--~------------------1-----1-----1-----1-----------------------,_-----------------------l 
Saint , et al (43) I I 31 I F I Enlarged sella turcica I l 
I I I I I I 
I I I I I I 
--~------------------~-----i-----1-----1-----------------------1r-----------------------~ Schmid, et al (46) I 1 43 I F I Chromophobe adenoma I I 
I I I I I I I I I I 1 
I I I I I I I I I I I I --~------------------,-----~----~-----1-----------------------1------------------------ l 
" I I 25 1l F I I Adenoma I 
I I I I I I I I I I --·------------------~-----~----1-----~----------------------1------------------------l 
" I I 44 I F I I Renal calculi, osteo- I 
I I I I I porosis 1 
---------------------~-----,-----~-----1-----------------------1------------------------l Shelburne and I I 26 I M I Temporal quadrant I Renal and ureteral I 
McLaughlin (47) I I I I field defects I stones; adenoma I 
---------------------~-----~-----~-----~----------------------i------------------------1 Summersiill (49) I I I I 11 I 
I I I I I I I I I I 
I I I I I I 
I I I I I 1l I I I I I 
I I I I I I ---------------------~-----~-----~-----~-----------------------,------------------------1 Verner and Morrison I I 19 I M I 1 I 
(52) I I I I · l I 
I I I I I I --~------------------~-----~-----,-----~-----------------------,------------------------r 
" I I 67 I F I Chromophobe adenoma I I 
I I I I I 
---------------------1-----~-----,-----~-----------------------,------------------------l Zollinger and Ellison 1 I 36 1 F I 1 I (63) I I I I I 1 I I I I I I 
I I I I I I I I I I I I --~------------------,-----~-----,-----,-----------------------4------------------------~ 
!I I 119 I F I I I 
I I I I I 1 
---------------------~-----~-----i-----+--------------·--------+---~-------------------1 ~ 
I I I I I I 
I I I I 1 
I I I I I 1 
I I I I I 1 
I I I I I I 
I I I I I 1 
I I I I I 1 
I I I I I 1 
I I I I I 
- 3-
PANCREAS G. I. TRACT OTHER 
SIGNIFICANT 
FAMILY HISTORY 
fi-----------------------r-----------------------.---------------------;r----------------
1 Islet cell adenomas I Refractory duodenal 1 Adrenal cortex- 1 
I I ulcer I nodular hyperplasia 1 !------------------------~-----------------------~---------------------t----------------
1 Non- beta cell islet I Diarrhea; recurrent I 1 Daughter- hypogl;i 
! tumor ( stomal ulcer I (cemiai beta celJ 
I I I 1 adenoma 1-----------------------~-----------------------l---------------------L---------------· 
!Multipl e islet cell !Hypertrophy of gastr ic IAdrenal cortex- mult .! 
adenomas l rugae !adenomas . Thyroid- 1 ! tmult . f ollicular aden f 
-----------------------+-----------------------~---------------------~---------------· I I I Islet cell adenoma St eat orrhea, diarrhea 1 1 
!Thickened duodenum with l I 
!ulcer, esophagitis 1 I 
-----------------------+------------------------~---------------------~---------------· 
1Islet cell hyperplasia IDuodenal ulcer , j e j unal fAdrenal hyperpla~ia I 
land adenoma lulcers , esophagitis , tand adenoma I I !parietal cell hypertrop~ Duodenal hamartoma 1 
1 !Hypersecretion 1
1 
I 
I I ~-----------------------+-----------------------~---------------------1---------------· 
INon- beta cell adenomas IDiarrhea !Primary amenorrhea lFather- chromoph< 
land hyperplas i a 16 jejunal ulcers •1 fparath., pan, ac I I ,-----------------------~-----------------------1----------------------~---------------· 
1Hypoglycemia; islet I fThyroid-colloid nodu-1 
I cell adenoma and ad eno-l 11ar goitre I 
lmatosis I I I 1-----------------------J-----------------------~---------------------~---------------· 
!convulsions _. ? islet I ~eripancreatic lymph I 
1cell adenoma 1 jnode I 
,-----------------------1-----------------------~---------------------~---------------· 
1 1 fCushing 1 s, amenorrhea I Brother- hyperp< 
1 ! I ~hyroidism 
1-----------------------~-----------------------~---------------------,----------------· 
ili:ypoglycemia , 3 adeno- buodenal ulcer JtUopecia, loss of I 
r as of islets ! p.i bido 1 
1-----------------------;-----------------------;---------------------~-------------- · ~erplasia of islet p eep gastric glands 1 I 
f ells plce:r-duoden o- jejunal I I 
1 !flexure , 5 ulcers upper I I I vejun'1Jll, duodenum I I 
~----------------------~----------------------1r---------------------r--------------· ! Non-beta cell islet kefractory diarrhea I 1 
1 adenoma r I I 
r----------------------1r----------------------~--------------------~--------------· 
1 Islet cell tumor I Refractory diarrhea I I ~----------------------JL-----------------------r---------------------r---------------· I Non- bet a cell islet poarsened and edematous I lJlcer- father ant 
1 tumors Jnucosa of stomach and I fnother; hyperin: 
1 puodenum; melena I ~inism-sister 
r-----------------------r-----------------------~---------------------~--------------· 
1 Non-beta cell islet 12 jejunal ulcers; hyper~ Lymph node metastase~ 
( carcinoma l plasia- parietal cells I I 
r---------~-------------t-----------------------r---------------------r--------------· 
I I . I I 
1 I I I 
1 I I I 
1 I I I 
1 I I I 
1 1 I I 
1 I I I 
1 I I I 
I I I l 
REFERENCE PT . AGE SEX PITUITARY PARATHYROIDS 
----------------------------------------------------------------------------------------r----~· 
Zubrod , et al ( 64) I i 35 I M I Acromegaly; eosinophilif Renal calculi, dec . 1 
1 1 1 • and chromophobe adenqma1bone density; adenomas l 
I I I I I with 'h~rnerplastic foci 1 I I I I I U.JJ:-' I 
I I I I I 3 glands I 
I I I I I I 
I I I I I I 
I I I I I I 
----------------------L-----L-----L-----L-----------------------L-----------------------1 
- I I I I I I Underdahl, et al (50) 1 l 34 1 F 1 1 One tumor removed, 1 I l l I f persistent hyperparathy~ 
----------------------L-----L-----L-----L-----------------------L-----------------------1 
- I I I I l l 
" 1 140 f F 1 Chromophobe adenoma f 2 tumors 1 
-~--------------------r-----r-----r-----r-----------------------r-----------------------1 
" l I 50 l F 1 Intra-sellar tumor on 14 adenomas in 3 glands 1 
. I I I I x- ray I I 
I I I I l I 
-~--------------------r-----r-----r-----r-----------------------r-----------------------1 
" I l 36 I M 1 1 2 adenomas 1 
I l I I I I 
I I I I I I 
-:--~----------------li----!!;4---,;----~~~;~~~;;~;~-;~~gh~-~~=-,~~~~~;;-~~~~;;~;-~~-~ 
l 1 1 l largement sella 1 3 glands 1 
---------------------1------r-----r-----r-----------------------r-----------------------: 
" I l 28 I M 1 Large chromophobe aden; 3 adenomas 1 
I I I I oma I I 
~--------------------1r-----r-----r-----r-----------------------r-----------------------~ 
" I I 38 I M I 1 3 adenomatous glands 1 
~--------------------~-----r-----r-----r-----------------------r-----------------------r 
" I I 54 I M 1 No head exam I 4 adenomatous glands 1 
I I I I I 1 
I I I I l I 
~--------------------1-----1r-----r-----r-----------------------r----------------------~ 
Wermer (55) I V.P. I 40 I M l I I 
I I I I I 1 
I I I I I I 
I I I I I I ' 
I I I I I 1 
---------------------~----~----1-----~----------------------1-----------------------~ 
" IC. P. I 39 I F I Intra-sellar tumor I Inc. serum Ca 1 
---------------------1-----1r----1-----1r----------------------1r-----------------------l 
" I W. B. I 35 f F I Intra- sellar tumor on 1 Inc . serum Ca 1 
I I I I x- ray , I ---------------------~-----~-----1-----1-----------------------~----------------------; 
" I F .S. I 34 I F I Acromegaly; tumor- x- ra(y Adenomatous hyperplasif=i 
I I I I Eos . and chrom. aden . I all 4 glands . 1 
---------------------~-----~----1-----~----------------------1-----------------------; 
" I O. P. I 32 I F I A{}romegaly I • ---------------------~-----~-----~-----~----------------------1-----------------------J 
- I 
I 
I 
I 
I 
I 
I 
PANCREAS G.I. TRACT OTHER 
SIGNIFICANT 
FAMILY HISTORY 
1~~~~~~~-;~~~-~;~~~-~~~f~~;;~~;~~~~~~;~~~~~-Ti;;~~~~~~-~~;~;~i~---t--------------
ladenomas 1Jejunal ulcer, duodenal ltesticles i lymph node!, I lulcer, stomal ulcer, !adrenal cortical adenl 
1 le«t opic islet cells in lomas i follicular adenl 
I I duodenum lomas of thyroid l 
I I I I 
·-----------------------~-----------------------~---------------------~--------------· !Hypoglycemia; islet celi l l 
!adenoma l l l 
t-----------------------t-----------------------~---------------------l--------------
11Hypoglycemia 1 I l I I I ·-----------------------1-----------------------+--------------------~--------------· 
'1? hypoglycemia ,no tumor iDuodenal ulcer I l 
t t • I I aa opera J.on 1 1 1 
I · I I ~-----------------------~-----------------------+---------------------~-------------· 
aHypoglycemia !'Duodenal ulcer hAetastasizing bronchidl 
I I I 
1 1 1adenoma • I I I ~-----------------------+-----------------------~---------------------~--------------· t5 adenomas l l.Adrenal cortical I 
I I I I 
1 1 tadenoma 1 I I I 
·-----------------------~-----------------------~---------------------~--------------· lMult . islet cell tumors lDiffuse gastric polyposis Adenomatous nodules l 
!adenomatosis of islets IPeptic ulcer 1adrenal cortices I 
I I I I 
~-----------------------~-----------------------1---------------------~--------------· 13 islet cell tumors I ICyst of thyroid l ·-----------------------~-----------------------1-____________________ J ______________ , 
1 
ult . islet cell tumors iDiffuse gastric •Metastases to regiona~ 
1 •polyposis t'nodes 1 
I I I 
~-----------------------1-----~-----------------1---------------------;--------------· 
•Islet cell adenoma IGastrJ.c ulcer 1 I I !Islet cell adenoma in 1 1 
1 !duodenum 1 l 
·-----------------------1-----------------------1---------------------~--------------· 
!Hypoglycemia 1Duodenal ulcer fPrimary amenorrhea ! 
·-----------------------~-----------------------~--------------------~--------------· I . I I I fHypoglycema; adenoma- 1 :secondary amenorrhea 1 
ttosis of islets 1 I l 
:-----------------------;-----------------------;---------------------;--------------· !Hypoglycemia; adenoma- !Gastric ulcer; islet :secondary amenorrhea l 
ttosis c5f islets 1cell tumor of duodenum 1 1 
1-----------------------;-----------------------;---------------------i--------------· 
1 fDuodenal ulcer !Secondary amenorrhea 1 
1-----------------------;-----------------------~---------------------i--------------· 
i 
l I 
I I 
I I 
i i 
I 
I 
I 
I 
I 
I 
I 
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